跳至主要内容
临床试验/CTRI/2023/08/056609
CTRI/2023/08/056609尚未招募2 期

Efficacy of Individualized Homoeopathic Medicines in The Treatment of Grade-1 Non-Alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial - NI

The Calcutta Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Cases attending OPD with ultra-sonographic evidence of grade-1 fatty liver.
  • 2. Literate patients; ability to read and write in Bengali, Hindi, and/or English.
  • 3. Patients giving written informed consent

排除标准

  • 1.Cases too sick for consultation.
  • 2. Patient unwilling to take part or not giving consent to join the study.
  • 3. Diagnosed cases of viral hepatitis, Wilson disease, hemochromatosis,
  • celiac disease, liver cirrhosis, hepatocellular carcinoma or any other
  • malignancies or any uncontrolled systemic diseases, unstable mental or
  • psychiatric illness or other uncontrolled or life-threatening illness
  • affecting quality of life or any organ failure.
  • 4. Cases with history of usage of some drugs (e.g., amiodarone,
  • corticosteroids, methotrexate, tamoxifen, synthetic estrogens, valproic
  • acid, intravenous tetracycline, and highly active antiretroviral drugs)
  • 5. Self-reported immune compromised state.
  • 6. Alcohol or any other substance abuse and/or dependence.
  • 7. Pregnant and lactating women.
  • 8. Patient simultaneously taking part in other clinical trial in the same

研究者

发起方
The Calcutta Homoeopathic Medical College and Hospital

相似试验